Skip to main content
Top
Published in: Malaria Journal 1/2013

Open Access 01-12-2013 | Research

Regional and temporal trends in malaria commodity costs: an analysis of Global Fund data for 79 countries

Authors: Francis Wafula, Ambrose Agweyu, Kate Macintyre

Published in: Malaria Journal | Issue 1/2013

Login to get access

Abstract

Background

Although procurement consumes nearly 40% of Global Fund’s money, no analyses have been published to show how costs vary across regions and time. This paper presents an analysis of malaria-related commodity procurement data from 79 countries, as reported through the Global Fund’s price and quality reporting (PQR) system for the 2005–2012 period.

Methods

Data were analysed for the three most widely procured commodities for prevention, diagnosis and treatment of malaria. These were long-lasting insecticide-treated nets (LLINs), malaria rapid diagnostic tests (RDTs) and the artemether/lumefantrine (AL) combination treatment. Costs were compared across time (2005–2012), regions, and between individual procurement reported through the PQR and pooled procurement reported through the Global Fund’s voluntary pooled procurement (VPP) system. All costs were adjusted for inflation and reported in US dollars.

Results

The data included 1,514 entries reported from 79 countries over seven years. Of these, 492 entries were for LLINs, 330 for RDTs and 692 for AL. Considerable variations were seen by commodity, although none showed an increase in cost. The costs for LLINs, RDTs and AL all dropped significantly over the period of analysis. Regional variations were also seen, with the cost for all three commodities showing significant variations. The median cost for a single LLIN ranged from USD 4.3 in East Asia to USD 5.0 in West and Central Africa. The cost of a single RDT was lowest in West and Central Africa at US$ 0.57, and highest in the Latin American region at US$ 1.1. AL had the narrowest margin of between US$ 0.06 per tablet in sub-Saharan Africa and South Asia, and US$ 0.08 in the Latin American and Eastern Europe regions.

Conclusion

This paper concludes that global procurement costs do vary by region and have reduced overall over time. This suggests a mature market is operating when viewed from the global level, but regional variation needs further attention. Such analyses should be done more often to identify and correct market insufficiencies.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: World Malaria Report 2012. 2012, Geneva, Switzerland: World Health Organization WHO: World Malaria Report 2012. 2012, Geneva, Switzerland: World Health Organization
2.
go back to reference GFATM: Strategic Investments for Impact: Global Fund Results Report, 2012. 2012, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria GFATM: Strategic Investments for Impact: Global Fund Results Report, 2012. 2012, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria
3.
go back to reference GFATM: Update on the Price and Quality Reporting (PQR) System. 2010, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria GFATM: Update on the Price and Quality Reporting (PQR) System. 2010, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria
4.
go back to reference GFATM: Voluntary Pooled Procurement: Key Results (2009–2011). 2012, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria GFATM: Voluntary Pooled Procurement: Key Results (2009–2011). 2012, Geneva, Switzerland: Global Fund to Fight AIDS, TB and Malaria
5.
go back to reference GFATM: Rice and Quality Reporting (PQR) Data Caveats. 2012, Geneva, Switzerland: Global Fund to fight AIDS, Tuberculosis and Malaria, Accessed July 2012 GFATM: Rice and Quality Reporting (PQR) Data Caveats. 2012, Geneva, Switzerland: Global Fund to fight AIDS, Tuberculosis and Malaria, Accessed July 2012
6.
go back to reference GFATM: Grant Rating Methodology: Notes on the LFA Training (November 2010). 2010, Geneva, Switzerland: Global Fund to Fight Aids, TB and Malaria GFATM: Grant Rating Methodology: Notes on the LFA Training (November 2010). 2010, Geneva, Switzerland: Global Fund to Fight Aids, TB and Malaria
10.
go back to reference Folland S, Goodman A, Stano M: The Economics of Health and Health care. 1997, New Jersey: Simon & Schuster Company, 2 Folland S, Goodman A, Stano M: The Economics of Health and Health care. 1997, New Jersey: Simon & Schuster Company, 2
11.
go back to reference WHO: A system to improve Value for Money in LLIN procurement through market competition based on cost per year of effective coverage: Concept Note. 2011, Geneva: WHO Global Malaria Programme WHO: A system to improve Value for Money in LLIN procurement through market competition based on cost per year of effective coverage: Concept Note. 2011, Geneva: WHO Global Malaria Programme
12.
go back to reference WHO: Insecticide-Treated Mosquito Nets: A WHO Position Statement. 2007, Geneva: World Health Organization WHO: Insecticide-Treated Mosquito Nets: A WHO Position Statement. 2007, Geneva: World Health Organization
14.
go back to reference Boston Consulting Group: Artemisinin Scenario Analysis: Summary of findings. 2009 Boston Consulting Group: Artemisinin Scenario Analysis: Summary of findings. 2009
15.
go back to reference UNITAID: HIV, Tuberculosis and Malaria Medicines Landscape: Progress Report on Emerging Issues and Potential Opportunities to Improve Access. 2012, Geneva, Switzerland: UNITAID Secretariat, World Health Organization UNITAID: HIV, Tuberculosis and Malaria Medicines Landscape: Progress Report on Emerging Issues and Potential Opportunities to Improve Access. 2012, Geneva, Switzerland: UNITAID Secretariat, World Health Organization
16.
go back to reference Wilson PA, Aizenman Y: Value for Money in Malaria Programming: Issues and Opportunities, Working Paper 291. 2012, Washington, DC: Center for Global Development Wilson PA, Aizenman Y: Value for Money in Malaria Programming: Issues and Opportunities, Working Paper 291. 2012, Washington, DC: Center for Global Development
17.
go back to reference WHO: WHO Global Malaria Programme Information note on recommended selection criteria for procurement of malaria rapid diagnostic tests (RDTs) - 20 December 2012. 2012, Geneva: World Health Organization WHO: WHO Global Malaria Programme Information note on recommended selection criteria for procurement of malaria rapid diagnostic tests (RDTs) - 20 December 2012. 2012, Geneva: World Health Organization
18.
go back to reference Yukich J, Bennett A, Albertini A, Incardona S, Moonga H, Chisha Z, Hamainza B, Miller J, Keating J, Eisele T, Bell D: Reductions in artemisinin-based combination therapy consumption after the nationwide scale-up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg. 2012, 87: 437-446. 10.4269/ajtmh.2012.12-0127.PubMedCentralCrossRefPubMed Yukich J, Bennett A, Albertini A, Incardona S, Moonga H, Chisha Z, Hamainza B, Miller J, Keating J, Eisele T, Bell D: Reductions in artemisinin-based combination therapy consumption after the nationwide scale-up of routine malaria rapid diagnostic testing in Zambia. Am J Trop Med Hyg. 2012, 87: 437-446. 10.4269/ajtmh.2012.12-0127.PubMedCentralCrossRefPubMed
19.
go back to reference GFATM: Procurement Support Services Progress Report: June 2009 – Dec 2010: Supporting Grant Implementation & Influencing Market Dynamics for HIV/AIDS and Malaria Products. 2011, Geneva, Switzerland: GFATM GFATM: Procurement Support Services Progress Report: June 2009 – Dec 2010: Supporting Grant Implementation & Influencing Market Dynamics for HIV/AIDS and Malaria Products. 2011, Geneva, Switzerland: GFATM
Metadata
Title
Regional and temporal trends in malaria commodity costs: an analysis of Global Fund data for 79 countries
Authors
Francis Wafula
Ambrose Agweyu
Kate Macintyre
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2013
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-12-466

Other articles of this Issue 1/2013

Malaria Journal 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.